𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A brief history of the research and treatment of lung cancer from 1970 to 200

✍ Scribed by Robert L. Comis

Publisher
Springer
Year
2003
Tongue
English
Weight
145 KB
Volume
8
Category
Article
ISSN
1341-9625

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Paclitaxel, carboplatin, and topotecan i
Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung carcinoma : A Phase II trial of the Minnie Pearl Cancer Research Network
✍ John D. Hainsworth; Lisa H. Morrissey; Daniel C. Scullin Jr.; Gerry Ann Houston; πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The objective of this study was to evaluate the feasibility, toxicity, and efficacy of a novel three‐drug regimen containing paclitaxel, carboplatin, and topotecan followed by oral etoposide in the first‐line treatment of patients with small cell lung carcinoma. ## METHO

Gemcitabine and vinorelbine in the secon
Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients : A Minnie Pearl Cancer Research Network Phase II trial
✍ John D. Hainsworth; Howard A. Burris III; Sharlene Litchy; Joan B. Erland; Jerem πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 2 views

## BACKGROUND. Second-line chemotherapy for patients with nonsmall cell lung carcinoma has been ineffective due to the lack of activity of older agents following platinum-based therapy. This Phase II trial evaluated the feasibility, toxicity, and efficacy of two active new agents, gemcitabine and v

Multidisciplinary approach to the treatm
Multidisciplinary approach to the treatment of locally and regionally advanced non-small cell lung cancer: University of Miami experience
✍ K. S. Sridhar; R. J. Thurer; A. M. Markoe; H. T. Chatoor; G. Fountzilas; W. J. R πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 513 KB

An intensive multimodality therapy protocol incorporating neoadjuvant chemotherapy was initiated in July 1985 for patients with either borderline resectable or unresectable non-small cell carcinoma of the lung. Thirty-five patients, 21 men and 14 women were entered till March 1991. The median age wa

A comparative trial of LC9018 plus doxor
A comparative trial of LC9018 plus doxorubicin and doxorubicin alone for the treatment of malignant pleural effusion secondary to lung cancer
✍ Tomiya Masuno; Susumu Kishimoto; Takeshi Ogura; Takeshi Honma; Hisanobu Niitani; πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 565 KB

The efficacy and safety of intrapleural LC9018 (Yakult Co. Ltd., Tokyo, Japan) with or without doxorubicin (Adriamycin; Adria Laboratories, Columbus, OH) were evaluated in a randomized, controlled trial performed in 95 patients with malignant pleural effusions secondary to lung cancer. Seventy-six p